Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic index-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic index

Published:2024-09 Issue: Volume:490 Page:117034
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Stoddard Madison,Yuan Lin,Cooper Jodi,Carcillo Neumar Christine,Hibner Barbara,Gardner Humphrey,Chakravarty Arijit

Publisher

Elsevier BV

Reference39 articles.

1. The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics;Agoram;Drug Discov. Today,2007

2. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

3. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore;Ambrose;Clin. Infect. Dis.,2007

4. Approval summary: Gemtuzumab Ozogamicin in relapsed acute myeloid leukemia;Bross;Clin. Cancer Res.,2001

5. Abstract 1636: a model-based approach toward clinical pipeline optimization;Burton;Cancer Res.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP